Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

U.S.: Do Not Mix Merck Hepatitis Pill With HIV Drugs

April 30, 2012

The Food and Drug Administration (FDA) said Thursday it is changing the label for Merck & Co.'s hepatitis C virus (HCV) treatment Victrelis following studies indicating it should not be taken with some common HIV drugs.

"Co-administration [of the two drugs] ... is not recommended at this time because of the possibility of reducing the effectiveness of the medicines, permitting the amount of HCV or HIV ... in the blood to increase," FDA said.

Victrelis (boceprevir) was approved last May. FDA and Merck first warned about the issue in February after results of a drug interaction study of healthy patients who took Victrelis and the widely used HIV drug Norvir (ritonavir) as part of a combination protease inhibitor regimen. The study found Victrelis reduced the concentrations of HIV drugs in the blood.

A second, small clinical trial of 98 people presented last month also contributed to FDA's labeling decision, though its results were not as conclusive as the drug interaction study. Some of the HCV/HIV co-infected patients were given Victrelis plus peginterferon/ribavirin, while others received only peginterferon/ribavirin; all patients were given a type of HIV drug. Of 64 patients taking Victrelis, three had a rebound in their HIV, compared to four of the 34 taking the older combination HCV treatment.

Merck said it plans to conduct a larger drug interaction study of Victrelis with other HIV drugs. FDA said it will report any new information about Victrelis and those treatments when it becomes available.

View the announcement.

Back to other news for April 2012

Adapted from:
Reuters
04.26.2012


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
Talk to a Physician About HIV/Hepatitis Coinfection in Our "Ask the Experts" Forums
More News on Hepatitis C Treatment

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement